Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

Table 6 Association between biochemical markers of fibrosis and biochemical metabolic markers

Biochemical markers	Total cholesterol N = 161	HDL Cholesterol N = 153	LDL Cholesterol N = 153	Triglycerides N = 161	Insulin N = 60	C-Peptide N = 59
α₂-macroglobulin	-0.10 *	0.07	-0.09	0.01	0.41	0.42
	0.23 $	0.38	0.29	0.92	0.001	0.001
Apolipoprotein A1	0.30	0.77	0.10	-0.23	0.02	0.00
	<0.0001	<0.0001	0.21	0.003	0.87	0.99
Haptoglobin	0.14	-0.04	0.20	0.12	-0.01	0.19
	0.07	0.61	0.01	0.11	0.94	0.14
GGT	0.24	0.07	0.24	0.12	0.12	0.25
	0.002	0.40	0.002	0.14	0.36	0.06
Total bilirubin	0.03	0.14	0.05	-0.17	-0.06	-0.09
	0.74	0.09	0.50	0.03	0.62	0.48
FibroTest	-0.16	-0.11	-0.07	0.01	0.29	0.33
	0.04	0.17	0.40	0.89	0.02	0.01

*Spearman coefficient of correlation
$ Significance P value
There was no significant correlation between FT and its components with glucose and uricemia (data not shown).

ISSN: 1471-230X